Dar Zavain 4
4 · RECURSION PHARMACEUTICALS, INC. · Filed Jun 23, 2025
Insider Transaction Report
Form 4
Dar Zavain
Director
Transactions
- Award
Class A Common Stock
2025-06-18+22,016→ 132,893 total - Award
Stock Option (Right to Buy)
2025-06-18+44,031→ 44,031 totalExercise: $5.11Exp: 2035-06-18→ Class A Common Stock (44,031 underlying)
Footnotes (2)
- [F1]Represents a grant of restricted stock units automatically granted pursuant to the Issuer's Outside Director Compensation Policy. The restricted stock units will vest on the earlier of June 18, 2026 or the day prior to the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer.
- [F2]The shares subject to this option will vest and become exercisable on the earlier of June 18, 2026 or the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer.